Impact of insulin pumps on glycaemic control in a pump-nïve paediatric regional population

Journal of Paediatrics and Child Health

Volumn 48, Issue 3, 2012, Pages 247-252

  De Bock, Martin ^a   Gunn, Alistair Jan ^a,b   Holt, Jean Ann ^c   Derraik, José G B ^a   Reed, Peter ^c   Cutfield, Wayne ^a   Mouat, Fran ^c   Hofman, Paul ^a   Jefferies, Craig ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

adolescent; endocrinology; HbA1c; insulin pump; type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ARTICLE; CHILD; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE DURATION; DRUG DOSE INCREASE; ETHNICITY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, PEDIATRIC; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; NEW ZEALAND; RETROSPECTIVE STUDIES;

EID: 84858437935     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2011.02245.x     Document Type: Article

References (22)

1. Cohen D, Weintrob N, Benzaquen H, Galatzer A, Fayman G, Phillip M,. Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial. J. Pediatr. Endocrinol. Metab. 2003; 16: 1047-50.
2. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J,. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst. Rev. 2010; (1): CD005103.
3. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV,. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004; 27: 1554-8.
4. Meschi F, Beccaria L, Vanini R, Szulc M, Chiumello G,. Short-term subcutaneous insulin infusion in diabetic children. Comparison with three daily insulin injections. Acta Diabetol. Lat. 1982; 19: 371-5.
5. Nuboer R, Borsboom GJ, Zoethout JA, Koot HM, Bruining J,. Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison. Pediatr. Diabetes 2008; 9: 291-6.
6. Pozzilli P, Crino A, Schiaffini R, et al,. A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). Diabetes Technol. Ther. 2003; 5: 965-74.
7. Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J,. Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus. Pediatr. Diabetes 2008; 9: 472-9.
8. Weintrob N, Schechter A, Benzaquen H, et al,. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion. Arch. Pediatr. Adolesc. Med. 2004; 158: 677-84.
9. Danne T, Tamborlane W,. Insulin pumps in pediatrics: we have the technology. We have the evidence. Why are still so few kids using it? Pediatr. Diabetes 2006; 7: 2-3.
10. Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H,. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr. Diabetes 2009; 10: 52-8.
11. NICE. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus; 2008.
12. Reda E, Von Reitzenstein A, Dunn P,. Metabolic control with insulin pump therapy: the Waikato experience. N. Z. Med. J. 2007; 120: U2401.
13. Carter PJ, Cutfield WS, Hofman PL, et al,. Ethnicity and social deprivation independently influence metabolic control in children with type 1 diabetes. Diabetologia 2008; 51: 1835-42.
14. Hoogma R, Hoekstra J, Michels B, Levi M,. Comparison between multiple daily insulin injection therapy (MDI) and continuous subcutaneous insulin infusion therapy (CSII), results of the five nations study. Diabetes Res. Clin. Pract. 2006; 74: S144-7.
15. Centers for Disease Control and Prevention. A SAS program for the CDC growth charts. 2009.
16. Salmond C, Crampton P,. NZDep2001 index of deprivation user's manual. In: Department of Public Health, Wellington School of Medicine and Health Sciences; 2002.
17. Lenhard MJ, Reeves GD,. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch. Intern. Med. 2001; 161: 2293-300.
18. DCCT Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes control and complications trial. Diabetes Control and Complications Trial Research Group. J. Pediatr. 1994; 125: 177-88.
19. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP,. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001; 107: 351-6.
20. Ahern JA, Boland EA, Doane R, et al,. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr. Diabetes 2002; 3: 10-15.
21. Hanas R, Ludvigsson J,. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr. Diabetes 2006; 7 (Suppl. 4): 32-8.
22. Hofer SE, Heidtmann B, Raile K, et al,. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria. Pediatr. Diabetes 2009; 11: 116-21.